Methyldesorphine
Clinical data
Other names3-Hydroxy-6,N-dimethyl- 4,5-epoxymorphin-6-en
ATC code
  • none
Legal status
Legal status
Identifiers
  • (5α)-6,17-Dimethyl-6,7-didehydro-4,5-epoxymorphinan-3-ol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.036.474
Chemical and physical data
FormulaC18H21NO2
Molar mass283.371 g·mol−1
3D model (JSmol)
  • CC1=CC[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C
  • InChI=1S/C18H21NO2/c1-10-3-5-12-13-9-11-4-6-14(20)16-15(11)18(12,17(10)21-16)7-8-19(13)2/h3-4,6,12-13,17,20H,5,7-9H2,1-2H3/t12-,13+,17-,18-/m0/s1 ☒N
  • Key:CUFWYVOFDYVCPM-GGNLRSJOSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Methyldesorphine is an opioid analgesic. First synthesized in Germany in 1940 and patented in the US in 1952,[2] it has a high potential for abuse as with any potent opioid agonist, and is sometimes found along with desomorphine as a component of the home-made opioid mixture known as "Krokodil" used in Russia and the neighboring former Soviet republics.[3] It is approximately 15 times more potent than morphine as an analgesic[4][5] but if the 6-7 bond is saturated, the β isomer is some 50 times more potent than morphine.

Methyldesorphine is listed as a Schedule I Narcotic controlled substance under the Controlled Substances Act 1970 in the United States with a DEA ACSCN of 9302 and zero annual aggregate manufacturing quota. The free base conversion ratio of the hydrochloride is 0.89.[6]

See also

References

  1. ↑ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ↑ US patent 2694068, Payne GB, Pfister III K, "Δ6-Desoxymorphine Compounds and Process of Producing the Same", published 1952-08-05, issued 1954-09-11, assigned to Merck & Co., Inc.
  3. ↑ Savchuk SA, Barsegyan SS, Barsegyan IB, Kolesov GM (2008). "Chromatographic Study of Expert and Biological Samples Containing Desomorphine". Journal of Analytical Chemistry. 63 (4): 361–370. doi:10.1007/s10809-008-4009-5. S2CID 195068778.
  4. ↑ Casy AF, Parfitt RY (1986). Opioid Analgesics, Chemistry and Receptors. New York: Plenum Press. pp. 37–38. ISBN 0-306-42130-5.
  5. ↑ Lenz GR, Evans SM, Walters DE, Hopfinger AJ (1986). Opiates. Academic Press. p. 63. ISBN 978-0-12-443830-9.
  6. ↑ "Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.